Nanoparticle Formulations of Antioxidants for the Management of Oxidative Stress in Stroke: A Review
- PMID: 38002010
- PMCID: PMC10669285
- DOI: 10.3390/biomedicines11113010
Nanoparticle Formulations of Antioxidants for the Management of Oxidative Stress in Stroke: A Review
Abstract
Stroke is currently one of the primary causes of morbidity and mortality worldwide. Unfortunately, there has been a lack of effective stroke treatment. Therefore, novel treatment strategies are needed to decrease stroke-induced morbidity and promote the patient's quality of life. Reactive oxygen species (ROS) have been recognized as one of the major causes of brain injury after ischemic stroke. Antioxidant therapy seems to be an effective treatment in the management of oxidative stress relevant to inflammatory disorders like stroke. However, the in vivo efficacy of traditional anti-oxidative substances is greatly limited due to their non-specific distribution and poor localization in the disease region. In recent years, antioxidant nanoparticles (NPs) have demonstrated a clinical breakthrough for stroke treatment. Some NPs have intrinsic antioxidant properties and act as antioxidants to scavenge ROS. Moreover, NPs provide protection to the antioxidant agents/enzymes while effectively delivering them into unreachable areas like the brain. Because of their nanoscale dimensions, NPs are able to efficiently pass through the BBB, and easily reach the damaged site. Here, we discuss the challenges, recent advances, and perspectives of antioxidant NPs in stroke treatment.
Keywords: blood–brain barrier (BBB); brain; nanoparticles; oxidative stress; reactive oxygen species (ROS); stroke.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
N-Acetyl cysteine amide and cerium oxide nanoparticles as a drug delivery for ischemic stroke treatment: Inflammation and oxidative stress crosstalk.J Trace Elem Med Biol. 2023 Dec;80:127300. doi: 10.1016/j.jtemb.2023.127300. Epub 2023 Sep 18. J Trace Elem Med Biol. 2023. PMID: 37741051
-
Superior antioxidant and anti-ischemic neuroprotective effects of cerebrolysin in heat stroke following intoxication of engineered metal Ag and Cu nanoparticles: A comparative biochemical and physiological study with other stroke therapies.Prog Brain Res. 2021;266:301-348. doi: 10.1016/bs.pbr.2021.06.014. Epub 2021 Oct 6. Prog Brain Res. 2021. PMID: 34689862
-
Targeted Treatment of Ischemic Stroke by Bioactive Nanoparticle-Derived Reactive Oxygen Species Responsive and Inflammation-Resolving Nanotherapies.ACS Nano. 2021 Oct 26;15(10):16076-16094. doi: 10.1021/acsnano.1c04753. Epub 2021 Oct 4. ACS Nano. 2021. PMID: 34606239
-
Therapeutic targets of oxidative/nitrosative stress and neuroinflammation in ischemic stroke: Applications for natural product efficacy with omics and systemic biology.Pharmacol Res. 2020 Aug;158:104877. doi: 10.1016/j.phrs.2020.104877. Epub 2020 May 12. Pharmacol Res. 2020. PMID: 32407958 Review.
-
Antioxidant Nanotherapies for the Treatment of Inflammatory Diseases.Front Bioeng Biotechnol. 2020 Mar 18;8:200. doi: 10.3389/fbioe.2020.00200. eCollection 2020. Front Bioeng Biotechnol. 2020. PMID: 32258013 Free PMC article. Review.
Cited by
-
The Influence of Oxidative Stress Markers in Patients with Ischemic Stroke.Biomolecules. 2024 Sep 6;14(9):1130. doi: 10.3390/biom14091130. Biomolecules. 2024. PMID: 39334896 Free PMC article. Review.
-
Emerging Promise of Green Synthesized Metallic Nanoparticles for the Management of Neurological Disorders.Curr Pharm Des. 2025;31(5):344-359. doi: 10.2174/0113816128337464240930042205. Curr Pharm Des. 2025. PMID: 39400023 Review.
-
Gold Nanoparticles in Neurological Diseases: A Review of Neuroprotection.Int J Mol Sci. 2024 Feb 17;25(4):2360. doi: 10.3390/ijms25042360. Int J Mol Sci. 2024. PMID: 38397037 Free PMC article. Review.
-
Nanozymes in neuropathic pain: strategies bridging oxidative stress, mitochondrial repair, and neuroimmune modulation for targeted therapy.J Neuroinflammation. 2025 Jun 12;22(1):156. doi: 10.1186/s12974-025-03456-w. J Neuroinflammation. 2025. PMID: 40506712 Free PMC article. Review.
-
Advancing stroke therapy: the potential of MOF-based nanozymes in biomedical applications.Front Bioeng Biotechnol. 2024 May 9;12:1363227. doi: 10.3389/fbioe.2024.1363227. eCollection 2024. Front Bioeng Biotechnol. 2024. PMID: 38798955 Free PMC article. Review.
References
-
- Yu W., Xuan C., Liu B., Zhou L., Yin N., Gong E., Zhang Z., Li Y., Zhang K., Shi J. Carrier-free programmed spherical nucleic acid for effective ischemic stroke therapy via self-delivery antisense oligonucleotide. Nano Res. 2022;16:735–745. doi: 10.1007/s12274-022-4402-7. - DOI
-
- Li Y., Zhang X., Qi Z., Guo X., Liu X., Shi W., Liu Y., Du L. The enhanced protective effects of salvianic acid A: A functionalized nanoparticles against ischemic stroke through increasing the permeability of the blood-brain barrier. Nano Res. 2020;13:2791–2802. doi: 10.1007/s12274-020-2930-6. - DOI
Publication types
LinkOut - more resources
Full Text Sources